Carnegie Mellon University
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 7, 2025), Carnegie Mellon University reported 6 stock positions worth $136.7 million. Its top holding was Duolingo (DUOL) at 74.7% of the portfolio, followed by Invesco QQQ Trust Series 1 (QQQ, 22.8%) and PDD (PDD, 2.5%). Compared with Q3 2024, it opened 2 new positions and reduced 1. The biggest buy was a new position in Invesco QQQ Trust Series 1 (QQQ) and the biggest sale Duolingo (DUOL, shares −8%).
- Most Recent 13F
- Q2 2026
- Location
- Pittsburgh, PA
- CIK
- 0001039067
- Portfolio Value
- $136.7M (Q4 2024)
- SEC Filing
- 0000898432-25-000100 ↗ filed Feb 7, 2025
Holdings Value
Holdings 6 stocks · $136.7M
| DUOL Duolingo | 74.68% | 314,814 | $102.1M | Reduce -8.3% |
| QQQ Invesco QQQ Trust Series 1 | 22.76% | 60,849 | $31.1M | New |
| PDD PDD Holdings Inc. | 2.51% | 35,322 | $3.4M | New |
| LONGEVITY HEALTH HLDGS INC filed as CARMELL CORPORATION | 0.03% | 134,469 | $38K | No change |
| IHT Innsuites Hospitality Trust | 0.02% | 10,000 | $22K | No change |
| PREDICTIVE ONCOLOGY INC | 0.01% | 10,358 | $8K | No change |
Portfolio Sells Q3 2024 → Q4 2024
| DUOL Duolingo | Reduce -8.3% | 74.68% | −25.23 |
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $78.9M | QQQ, DUOL, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q1 2026 | 5 | $64.3M | QQQ, DUOL, IHT, LONGEVITY HEALTH HLDGS INC, AGPU |
| Q4 2025 | 5 | $89.3M | DUOL, QQQ, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q3 2025 | 5 | $131.6M | DUOL, QQQ, IHT, PREDICTIVE ONCOLOGY INC, LONGEVITY HEALTH HLDGS INC |
| Q2 2025 | 5 | $154.6M | DUOL, QQQ, IHT, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC |
| Q1 2025 | 6 | $129.0M | DUOL, QQQ, PDD, IHT, LONGEVITY HEALTH HLDGS INC |
| Q4 2024 | 6 | $136.7M | DUOL, QQQ, PDD, LONGEVITY HEALTH HLDGS INC, IHT |
| Q3 2024 | 4 | $96.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q2 2024 | 4 | $73.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q1 2024 | 6 | $80.1M | DUOL, VERA, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC, NBSE |